摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl N-[3-[3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propoxy]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]propyl]carbamate | 1382469-17-1

中文名称
——
中文别名
——
英文名称
tert-butyl N-[3-[3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propoxy]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]propyl]carbamate
英文别名
——
tert-butyl N-[3-[3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propoxy]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]propyl]carbamate化学式
CAS
1382469-17-1
化学式
C28H47BN2O8
mdl
——
分子量
550.501
InChiKey
DOWASSLRKUDXJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.57
  • 重原子数:
    39
  • 可旋转键数:
    15
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    114
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] POLYCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS POLYCYCLIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
    申请人:CELLCEUTIX CORP
    公开号:WO2014093225A3
    公开(公告)日:2014-08-07
  • Synthetic Mimics of Antimicrobial Peptides with Immunomodulatory Responses
    作者:Hitesh D. Thaker、Abhigyan Som、Furkan Ayaz、Dahui Lui、Wenxi Pan、Richard W. Scott、Juan Anguita、Gregory N. Tew
    DOI:10.1021/ja303304j
    日期:2012.7.11
    A new series of aryl-based synthetic mimics of antimicrobial peptides (SMAMPs) with antimicrobial activity and selectivity have been developed via systematic tuning of the aromatic groups and charge. The addition of a pendant aromatic group improved the antimicrobial activity against Gram-negative bacteria, while the addition of charge improved the selectivity. SMAMP 4 with six charges and a naphthalene central ring demonstrated a selectivity of 200 against both Staphylococcus aureus and Escherichia coli, compared with a selectivity of 8 for the peptide MSI-78. In addition to the direct antimicrobial activity, SMAMP 4 exhibited specific immunomodulatory activities in macrophages both in the presence and in the absence of lipopolysaccharide, a TLR agonist. SMAMP 4 also induced the production of a neutrophil chemoattractant, murine KC, in mouse primary cells. This is the first nonpeptidic SMAMP demonstrating both good antimicrobial and immunomodulatory activities.
  • Role of Amphiphilicity in the Design of Synthetic Mimics of Antimicrobial Peptides with Gram-Negative Activity
    作者:Hitesh D. Thaker、Alper Cankaya、Richard W. Scott、Gregory N. Tew
    DOI:10.1021/ml300307b
    日期:2013.5.9
    Two new series of aryl SMAMPs (synthetic mimics of antimicrobial peptides) with facially amphiphilic (FA) and disrupted amphiphilic (DA) topologies were designed and synthesized to directly assess the role of amphiphilicity on their antimicrobial activity against Gram-positive and Gram-negative bacteria in closely related structures. The FA SMAMPs displayed broad spectrum antimicrobial activity against both Gram-positive S. aureus and Gram-negative E. coli, whereas the DA SMAMPs, which contained a polar amide bond in between the hydrophobic moieties, only exhibited activity toward S. aureus with increasing hydrophobicity. The integy moment (IW) was used to quantify the amphiphilicity of the SMAMPs and confirmed that it is critical for the design of SMAMPs with Gram-negative activity.
  • [EN] CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS CYCLIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
    申请人:POLYMEDIX INC
    公开号:WO2013090185A1
    公开(公告)日:2013-06-20
    The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.
    本发明提供了用于抑制微生物生长的化合物或其药学上可接受的盐;用于治疗患有微生物感染、口腔炎、眼科感染、耳科感染、癌症或结核分枝杆菌感染的哺乳动物;用于抑制结核分枝杆菌物种的生长;用于调节哺乳动物的免疫反应;或用于拮抗非分级肝素、低分子肝素或肝素/低分子肝素衍生物。
查看更多